The global preclinical research market continues to benefit from sustained pharmaceutical and academic investment in ...
A patented near-infrared spectroscopy (NIRS) platform, clinically validated muscle oxygenation measurement (SmO ), dual nitric oxide sensing, and an AI-powered training platform position NNOXX as the ...
5dOpinion
Opinion: Every day, patients die waiting for transplants. But a Yale doctor offers reason for hope
Over the past year, our liver transplant program at Yale New Haven Hospital has undergone meaningful growth and ...
Discover Alexis Carrel's groundbreaking Nobel-winning techniques in vascular repair and organ transplantation that ...
Guidance validates the comprehensive approach Bracco has advanced for more than three decades NEEDHAM, Mass., April 13, 2026 /PRNewswire/ -- Bracco, the market leader in diagnostic imaging and the ...
Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down ...
Another risk for investors to consider is that the company remains unprofitable. While the company seems to have reached an ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Obesity and hypertension frequently coexist and are major contributors to cardiovascular disease. 1,2 Beyond hemodynamic and ...
SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today ...
High blood pressure is the main modifiable risk factor for preventing cardiovascular events in people who have had a stroke or transient ischaemic attack; however, only approximately one in three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results